Teva Pharmaceuticals @TevaUSA
Increased availability of #complexgenerics could save the health system over $1.3 billion annually. Christine Baeder, Teva’s SVP & COO, discussed solutions to address regulatory delays that impede patient access at @TheHillEvents. https://t.co/1xx3G9vNCv #TheHillRx #healthpolicy https://t.co/uZttvJPT1J — PolitiTweet.org